aluates Reports

$ 0.0

Automative

Global Albumin (as Excipient) Market Research Report 2026

Published Date: 2026-03-02

Report Code: QYRE-Auto-10I9044

Global Albumin as Excipient Market Outlook 2022

BUY CHAPTERS

Global Albumin (as Excipient) Market Research Report 2026

Code: QYRE-Auto-10I9044

Report

2026-03-02

Pages:126

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CSL Limited

Grifols S A

Octapharma AG

Hualan Bio

CBPO

Shanghai Raas

Kedrion S p A

LFB Group

Takeda

Albumin (as Excipient) Market Size

The global Albumin (as Excipient) market was valued at US$ 1682 million in 2025 and is anticipated to reach US$ 2598 million by 2032, at a CAGR of 6.5% from 2026 to 2032.

Albumin (as Excipient) Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Albumin (as Excipient) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Albumin excipients refer to human serum albumin (HSA) or recombinant human serum albumin (rHSA) used as excipients in biopharmaceuticals. Their primary functions include stabilizing the structure and activity of protein drugs, enhancing drug solubility and bioavailability as carriers, and serving as nutritional components in vaccines and cell culture media. With the advancement of biologics and vaccine development, the application of albumin excipients in drug formulations is becoming increasingly widespread.In 2024, global Albumin (as Excipient) production reached approximately 440 mt, with an average global market price of around US$ 3622 per kg.

The albumin excipient market is experiencing unprecedented growth opportunities due to the global rise in chronic diseases, rapid expansion of the biopharmaceutical industry, and increasing demand for efficient drug delivery systems. Particularly in vaccine development and gene therapy, albumin excipients have become indispensable components due to their excellent biocompatibility and stability. Furthermore, advancements in recombinant albumin technologies have made the production process safer and more controllable, further driving market growth.

Despite the promising prospects, the albumin excipient market faces several challenges. Firstly, the source and quality control of raw materials are critical, especially the supply of human-derived albumin, which may affect production stability. Secondly, stringent regulatory requirements and quality standards make the research and development process complex and time-consuming. Additionally, increasing market competition from emerging enterprises and technologies may threaten the market share of existing companies.

Downstream demand is primarily concentrated in areas such as vaccines, cell culture media, protein drugs, and gene therapies. With the rise of personalized medicine and precision therapy, the demand for high-quality excipients continues to increase. Moreover, the growing aging population globally is driving the demand for chronic disease treatment drugs, thereby boosting the need for albumin excipients.

The main raw materials for albumin excipients include human serum albumin and recombinant bovine serum albumin. Human serum albumin is primarily sourced from plasma collection; however, its supply is limited by the number of blood donors and ethical issues related to plasma collection. On the other hand, recombinant bovine serum albumin production relies on bioreactor technology, which has higher production costs and technical requirements. Therefore, the stable supply and cost control of raw materials are key factors influencing the development of the albumin excipient market.

This report delivers a comprehensive overview of the global Albumin (as Excipient) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Albumin (as Excipient). The Albumin (as Excipient) market size, estimates, and forecasts are provided in terms of sales volume (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Albumin (as Excipient) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Albumin (as Excipient) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Albumin (as Excipient) Market Report

Report Metric	Details
Report Name	Albumin (as Excipient) Market
Accounted market size in 2025	US$ 1682 in million
Forecasted market size in 2032	US$ 2598 million
CAGR	6.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	20-25% Concentrations 5% Concentrations
by Application	Cell Culture Media Medical Excipient
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Tiantan Bio, Pailin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Albumin (as Excipient) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Albumin (as Excipient) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Albumin (as Excipient) Market growing?

Ans: The Albumin (as Excipient) Market witnessing a CAGR of 6.5% during the forecast period 2026-2032.

What is the Albumin (as Excipient) Market size in 2032?

Ans: The Albumin (as Excipient) Market size in 2032 will be US$ 2598 million.

Who are the main players in the Albumin (as Excipient) Market report?

Ans: The main players in the Albumin (as Excipient) Market are CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Tiantan Bio, Pailin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio

What are the Application segmentation covered in the Albumin (as Excipient) Market report?

Ans: The Applications covered in the Albumin (as Excipient) Market report are Cell Culture Media, Medical Excipient

What are the Type segmentation covered in the Albumin (as Excipient) Market report?

Ans: The Types covered in the Albumin (as Excipient) Market report are 20-25% Concentrations, 5% Concentrations

1 Albumin (as Excipient) Market Overview

1.1 Product Definition

1.2 Albumin (as Excipient) by Type

1.2.1 Global Albumin (as Excipient) Market Value by Type: 2025 vs 2032

1.2.2 20-25% Concentrations

1.2.3 5% Concentrations

1.3 Albumin (as Excipient) by Application

1.3.1 Global Albumin (as Excipient) Market Value by Application: 2025 vs 2032

1.3.2 Cell Culture Media

1.3.3 Medical Excipient

1.4 Global Albumin (as Excipient) Market Size Estimates and Forecasts

1.4.1 Global Albumin (as Excipient) Revenue 2021–2032

1.4.2 Global Albumin (as Excipient) Sales 2021–2032

1.4.3 Global Albumin (as Excipient) Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Albumin (as Excipient) Market Competition by Manufacturers

2.1 Global Albumin (as Excipient) Sales Market Share by Manufacturers (2021–2026)

2.2 Global Albumin (as Excipient) Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Albumin (as Excipient) Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Albumin (as Excipient), Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Albumin (as Excipient), Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Albumin (as Excipient), Product Types and Applications

2.7 Global Key Manufacturers of Albumin (as Excipient), Date of Entry into the Industry

2.8 Global Albumin (as Excipient) Market Competitive Situation and Trends

2.8.1 Global Albumin (as Excipient) Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Albumin (as Excipient) Players Market Share by Revenue

2.8.3 Global Albumin (as Excipient) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Albumin (as Excipient) Market Scenario by Region

3.1 Global Albumin (as Excipient) Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Albumin (as Excipient) Sales by Region: 2021–2032

3.2.1 Global Albumin (as Excipient) Sales by Region: 2021–2026

3.2.2 Global Albumin (as Excipient) Sales by Region: 2027–2032

3.3 Global Albumin (as Excipient) Revenue by Region: 2021–2032

3.3.1 Global Albumin (as Excipient) Revenue by Region: 2021–2026

3.3.2 Global Albumin (as Excipient) Revenue by Region: 2027–2032

3.4 North America Albumin (as Excipient) Market Facts & Figures by Country

3.4.1 North America Albumin (as Excipient) Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Albumin (as Excipient) Sales by Country (2021–2032)

3.4.3 North America Albumin (as Excipient) Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Albumin (as Excipient) Market Facts & Figures by Country

3.5.1 Europe Albumin (as Excipient) Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Albumin (as Excipient) Sales by Country (2021–2032)

3.5.3 Europe Albumin (as Excipient) Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Albumin (as Excipient) Market Facts & Figures by Region

3.6.1 Asia Pacific Albumin (as Excipient) Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Albumin (as Excipient) Sales by Region (2021–2032)

3.6.3 Asia Pacific Albumin (as Excipient) Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Albumin (as Excipient) Market Facts & Figures by Country

3.7.1 Latin America Albumin (as Excipient) Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Albumin (as Excipient) Sales by Country (2021–2032)

3.7.3 Latin America Albumin (as Excipient) Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Albumin (as Excipient) Market Facts & Figures by Country

3.8.1 Middle East and Africa Albumin (as Excipient) Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Albumin (as Excipient) Sales by Country (2021–2032)

3.8.3 Middle East and Africa Albumin (as Excipient) Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Albumin (as Excipient) Sales by Type (2021–2032)

4.1.1 Global Albumin (as Excipient) Sales by Type (2021–2026)

4.1.2 Global Albumin (as Excipient) Sales by Type (2027–2032)

4.1.3 Global Albumin (as Excipient) Sales Market Share by Type (2021–2032)

4.2 Global Albumin (as Excipient) Revenue by Type (2021–2032)

4.2.1 Global Albumin (as Excipient) Revenue by Type (2021–2026)

4.2.2 Global Albumin (as Excipient) Revenue by Type (2027–2032)

4.2.3 Global Albumin (as Excipient) Revenue Market Share by Type (2021–2032)

4.3 Global Albumin (as Excipient) Price by Type (2021–2032)

5 Segment by Application

5.1 Global Albumin (as Excipient) Sales by Application (2021–2032)

5.1.1 Global Albumin (as Excipient) Sales by Application (2021–2026)

5.1.2 Global Albumin (as Excipient) Sales by Application (2027–2032)

5.1.3 Global Albumin (as Excipient) Sales Market Share by Application (2021–2032)

5.2 Global Albumin (as Excipient) Revenue by Application (2021–2032)

5.2.1 Global Albumin (as Excipient) Revenue by Application (2021–2026)

5.2.2 Global Albumin (as Excipient) Revenue by Application (2027–2032)

5.2.3 Global Albumin (as Excipient) Revenue Market Share by Application (2021–2032)

5.3 Global Albumin (as Excipient) Price by Application (2021–2032)

6 Key Companies Profiled

6.1 CSL

6.1.1 CSL Company Information

6.1.2 CSL Description and Business Overview

6.1.3 CSL Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 CSL Albumin (as Excipient) Product Portfolio

6.1.5 CSL Recent Developments/Updates

6.2 Grifols

6.2.1 Grifols Company Information

6.2.2 Grifols Description and Business Overview

6.2.3 Grifols Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Grifols Albumin (as Excipient) Product Portfolio

6.2.5 Grifols Recent Developments/Updates

6.3 Takeda

6.3.1 Takeda Company Information

6.3.2 Takeda Description and Business Overview

6.3.3 Takeda Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Takeda Albumin (as Excipient) Product Portfolio

6.3.5 Takeda Recent Developments/Updates

6.4 Octapharma

6.4.1 Octapharma Company Information

6.4.2 Octapharma Description and Business Overview

6.4.3 Octapharma Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Octapharma Albumin (as Excipient) Product Portfolio

6.4.5 Octapharma Recent Developments/Updates

6.5 Hualan Bio

6.5.1 Hualan Bio Company Information

6.5.2 Hualan Bio Description and Business Overview

6.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Hualan Bio Albumin (as Excipient) Product Portfolio

6.5.5 Hualan Bio Recent Developments/Updates

6.6 CBPO

6.6.1 CBPO Company Information

6.6.2 CBPO Description and Business Overview

6.6.3 CBPO Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 CBPO Albumin (as Excipient) Product Portfolio

6.6.5 CBPO Recent Developments/Updates

6.7 Shanghai RAAS

6.7.1 Shanghai RAAS Company Information

6.7.2 Shanghai RAAS Description and Business Overview

6.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Shanghai RAAS Albumin (as Excipient) Product Portfolio

6.7.5 Shanghai RAAS Recent Developments/Updates

6.8 Kedrion

6.8.1 Kedrion Company Information

6.8.2 Kedrion Description and Business Overview

6.8.3 Kedrion Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Kedrion Albumin (as Excipient) Product Portfolio

6.8.5 Kedrion Recent Developments/Updates

6.9 LFB Group

6.9.1 LFB Group Company Information

6.9.2 LFB Group Description and Business Overview

6.9.3 LFB Group Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 LFB Group Albumin (as Excipient) Product Portfolio

6.9.5 LFB Group Recent Developments/Updates

6.10 Tiantan Bio

6.10.1 Tiantan Bio Company Information

6.10.2 Tiantan Bio Description and Business Overview

6.10.3 Tiantan Bio Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Tiantan Bio Albumin (as Excipient) Product Portfolio

6.10.5 Tiantan Bio Recent Developments/Updates

6.11 Pailin Bio

6.11.1 Pailin Bio Company Information

6.11.2 Pailin Bio Description and Business Overview

6.11.3 Pailin Bio Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Pailin Bio Albumin (as Excipient) Product Portfolio

6.11.5 Pailin Bio Recent Developments/Updates

6.12 Boya Bio

6.12.1 Boya Bio Company Information

6.12.2 Boya Bio Description and Business Overview

6.12.3 Boya Bio Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Boya Bio Albumin (as Excipient) Product Portfolio

6.12.5 Boya Bio Recent Developments/Updates

6.13 Yuanda Shuyang

6.13.1 Yuanda Shuyang Company Information

6.13.2 Yuanda Shuyang Description and Business Overview

6.13.3 Yuanda Shuyang Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Yuanda Shuyang Albumin (as Excipient) Product Portfolio

6.13.5 Yuanda Shuyang Recent Developments/Updates

6.14 Weiguang Bio

6.14.1 Weiguang Bio Company Information

6.14.2 Weiguang Bio Description and Business Overview

6.14.3 Weiguang Bio Albumin (as Excipient) Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Weiguang Bio Albumin (as Excipient) Product Portfolio

6.14.5 Weiguang Bio Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Albumin (as Excipient) Industry Chain Analysis

7.2 Albumin (as Excipient) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Albumin (as Excipient) Production Mode & Process Analysis

7.4 Albumin (as Excipient) Sales and Marketing

7.4.1 Albumin (as Excipient) Sales Channels

7.4.2 Albumin (as Excipient) Distributors

7.5 Albumin (as Excipient) Customer Analysis

8 Albumin (as Excipient) Market Dynamics

8.1 Albumin (as Excipient) Industry Trends

8.2 Albumin (as Excipient) Market Drivers

8.3 Albumin (as Excipient) Market Challenges

8.4 Albumin (as Excipient) Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

CSL Limited

Grifols S A

Octapharma AG

Hualan Bio

CBPO

Shanghai Raas

Kedrion S p A

LFB Group

Takeda

List of Tables

Table 1. Global Albumin (as Excipient) Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Albumin (as Excipient) Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Albumin (as Excipient) Market Competitive Situation by Manufacturers in 2025

Table 4. Global Albumin (as Excipient) Sales (MT) of Key Manufacturers (2021–2026)

Table 5. Global Albumin (as Excipient) Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Albumin (as Excipient) Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Albumin (as Excipient) Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Albumin (as Excipient) Average Price (USD/Kg) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Albumin (as Excipient), Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Albumin (as Excipient), Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Albumin (as Excipient), Product Types and Applications

Table 12. Global Key Manufacturers of Albumin (as Excipient), Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Albumin (as Excipient) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Albumin (as Excipient) Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Albumin (as Excipient) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Albumin (as Excipient) Sales by Region (MT), 2021–2026

Table 18. Global Albumin (as Excipient) Sales Market Share by Region (2021–2026)

Table 19. Global Albumin (as Excipient) Sales by Region (MT), 2027–2032

Table 20. Global Albumin (as Excipient) Sales Market Share by Region (2027–2032)

Table 21. Global Albumin (as Excipient) Revenue by Region (US$ Million), 2021–2026

Table 22. Global Albumin (as Excipient) Revenue Market Share by Region (2021–2026)

Table 23. Global Albumin (as Excipient) Revenue by Region (US$ Million), 2027–2032

Table 24. Global Albumin (as Excipient) Revenue Market Share by Region (2027–2032)

Table 25. North America Albumin (as Excipient) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Albumin (as Excipient) Sales by Country (MT), 2021–2026

Table 27. North America Albumin (as Excipient) Sales by Country (MT), 2027–2032

Table 28. North America Albumin (as Excipient) Revenue by Country (US$ Million), 2021–2026

Table 29. North America Albumin (as Excipient) Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Albumin (as Excipient) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Albumin (as Excipient) Sales by Country (MT), 2021–2026

Table 32. Europe Albumin (as Excipient) Sales by Country (MT), 2027–2032

Table 33. Europe Albumin (as Excipient) Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Albumin (as Excipient) Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Albumin (as Excipient) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Albumin (as Excipient) Sales by Region (MT), 2021–2026

Table 37. Asia Pacific Albumin (as Excipient) Sales by Region (MT), 2027–2032

Table 38. Asia Pacific Albumin (as Excipient) Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Albumin (as Excipient) Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Albumin (as Excipient) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Albumin (as Excipient) Sales by Country (MT), 2021–2026

Table 42. Latin America Albumin (as Excipient) Sales by Country (MT), 2027–2032

Table 43. Latin America Albumin (as Excipient) Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Albumin (as Excipient) Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Albumin (as Excipient) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Albumin (as Excipient) Sales by Country (MT), 2021–2026

Table 47. Middle East and Africa Albumin (as Excipient) Sales by Country (MT), 2027–2032

Table 48. Middle East and Africa Albumin (as Excipient) Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Albumin (as Excipient) Revenue by Country (US$ Million), 2027–2032

Table 50. Global Albumin (as Excipient) Sales (MT) by Type (2021–2026)

Table 51. Global Albumin (as Excipient) Sales (MT) by Type (2027–2032)

Table 52. Global Albumin (as Excipient) Sales Market Share by Type (2021–2026)

Table 53. Global Albumin (as Excipient) Sales Market Share by Type (2027–2032)

Table 54. Global Albumin (as Excipient) Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Albumin (as Excipient) Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Albumin (as Excipient) Revenue Market Share by Type (2021–2026)

Table 57. Global Albumin (as Excipient) Revenue Market Share by Type (2027–2032)

Table 58. Global Albumin (as Excipient) Price (USD/Kg) by Type (2021–2026)

Table 59. Global Albumin (as Excipient) Price (USD/Kg) by Type (2027–2032)

Table 60. Global Albumin (as Excipient) Sales (MT) by Application (2021–2026)

Table 61. Global Albumin (as Excipient) Sales (MT) by Application (2027–2032)

Table 62. Global Albumin (as Excipient) Sales Market Share by Application (2021–2026)

Table 63. Global Albumin (as Excipient) Sales Market Share by Application (2027–2032)

Table 64. Global Albumin (as Excipient) Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Albumin (as Excipient) Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Albumin (as Excipient) Revenue Market Share by Application (2021–2026)

Table 67. Global Albumin (as Excipient) Revenue Market Share by Application (2027–2032)

Table 68. Global Albumin (as Excipient) Price (USD/Kg) by Application (2021–2026)

Table 69. Global Albumin (as Excipient) Price (USD/Kg) by Application (2027–2032)

Table 70. CSL Company Information

Table 71. CSL Description and Business Overview

Table 72. CSL Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 73. CSL Albumin (as Excipient) Product

Table 74. CSL Recent Developments/Updates

Table 75. Grifols Company Information

Table 76. Grifols Description and Business Overview

Table 77. Grifols Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 78. Grifols Albumin (as Excipient) Product

Table 79. Grifols Recent Developments/Updates

Table 80. Takeda Company Information

Table 81. Takeda Description and Business Overview

Table 82. Takeda Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 83. Takeda Albumin (as Excipient) Product

Table 84. Takeda Recent Developments/Updates

Table 85. Octapharma Company Information

Table 86. Octapharma Description and Business Overview

Table 87. Octapharma Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 88. Octapharma Albumin (as Excipient) Product

Table 89. Octapharma Recent Developments/Updates

Table 90. Hualan Bio Company Information

Table 91. Hualan Bio Description and Business Overview

Table 92. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 93. Hualan Bio Albumin (as Excipient) Product

Table 94. Hualan Bio Recent Developments/Updates

Table 95. CBPO Company Information

Table 96. CBPO Description and Business Overview

Table 97. CBPO Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 98. CBPO Albumin (as Excipient) Product

Table 99. CBPO Recent Developments/Updates

Table 100. Shanghai RAAS Company Information

Table 101. Shanghai RAAS Description and Business Overview

Table 102. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 103. Shanghai RAAS Albumin (as Excipient) Product

Table 104. Shanghai RAAS Recent Developments/Updates

Table 105. Kedrion Company Information

Table 106. Kedrion Description and Business Overview

Table 107. Kedrion Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 108. Kedrion Albumin (as Excipient) Product

Table 109. Kedrion Recent Developments/Updates

Table 110. LFB Group Company Information

Table 111. LFB Group Description and Business Overview

Table 112. LFB Group Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 113. LFB Group Albumin (as Excipient) Product

Table 114. LFB Group Recent Developments/Updates

Table 115. Tiantan Bio Company Information

Table 116. Tiantan Bio Description and Business Overview

Table 117. Tiantan Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 118. Tiantan Bio Albumin (as Excipient) Product

Table 119. Tiantan Bio Recent Developments/Updates

Table 120. Pailin Bio Company Information

Table 121. Pailin Bio Description and Business Overview

Table 122. Pailin Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 123. Pailin Bio Albumin (as Excipient) Product

Table 124. Pailin Bio Recent Developments/Updates

Table 125. Boya Bio Company Information

Table 126. Boya Bio Description and Business Overview

Table 127. Boya Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 128. Boya Bio Albumin (as Excipient) Product

Table 129. Boya Bio Recent Developments/Updates

Table 130. Yuanda Shuyang Company Information

Table 131. Yuanda Shuyang Description and Business Overview

Table 132. Yuanda Shuyang Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 133. Yuanda Shuyang Albumin (as Excipient) Product

Table 134. Yuanda Shuyang Recent Developments/Updates

Table 135. Weiguang Bio Company Information

Table 136. Weiguang Bio Description and Business Overview

Table 137. Weiguang Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)

Table 138. Weiguang Bio Albumin (as Excipient) Product

Table 139. Weiguang Bio Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Albumin (as Excipient) Distributors List

Table 143. Albumin (as Excipient) Customers List

Table 144. Albumin (as Excipient) Market Trends

Table 145. Albumin (as Excipient) Market Drivers

Table 146. Albumin (as Excipient) Market Challenges

Table 147. Albumin (as Excipient) Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Albumin (as Excipient)

Figure 2. Global Albumin (as Excipient) Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Albumin (as Excipient) Market Share by Type: 2025 & 2032

Figure 4. 20-25% Concentrations Product Picture

Figure 5. 5% Concentrations Product Picture

Figure 6. Global Albumin (as Excipient) Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Albumin (as Excipient) Market Share by Application: 2025 & 2032

Figure 8. Cell Culture Media

Figure 9. Medical Excipient

Figure 10. Global Albumin (as Excipient) Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Albumin (as Excipient) Market Size (US$ Million), 2021–2032

Figure 12. Global Albumin (as Excipient) Sales (MT), 2021–2032

Figure 13. Global Albumin (as Excipient) Average Price (USD/Kg), 2021–2032

Figure 14. Albumin (as Excipient) Report Years Considered

Figure 15. Albumin (as Excipient) Sales Share by Manufacturers in 2025

Figure 16. Global Albumin (as Excipient) Revenue Share by Manufacturers in 2025

Figure 17. Top 5 and Top 10 Global Albumin (as Excipient) Players: Market Share by Revenue in Albumin (as Excipient) in 2025

Figure 18. Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 19. Global Albumin (as Excipient) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 20. North America Albumin (as Excipient) Sales Market Share by Country (2021–2032)

Figure 21. North America Albumin (as Excipient) Revenue Market Share by Country (2021–2032)

Figure 22. U.S. Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 23. Canada Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Europe Albumin (as Excipient) Sales Market Share by Country (2021–2032)

Figure 25. Europe Albumin (as Excipient) Revenue Market Share by Country (2021–2032)

Figure 26. Germany Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. France Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. U.K. Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Italy Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Russia Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Asia Pacific Albumin (as Excipient) Sales Market Share by Region (2021–2032)

Figure 32. Asia Pacific Albumin (as Excipient) Revenue Market Share by Region (2021–2032)

Figure 33. China Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Japan Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. South Korea Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. India Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Australia Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Taiwan Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Indonesia Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Thailand Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Malaysia Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Philippines Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Latin America Albumin (as Excipient) Sales Market Share by Country (2021–2032)

Figure 44. Latin America Albumin (as Excipient) Revenue Market Share by Country (2021–2032)

Figure 45. Mexico Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Brazil Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Argentina Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Middle East and Africa Albumin (as Excipient) Sales Market Share by Country (2021–2032)

Figure 49. Middle East and Africa Albumin (as Excipient) Revenue Market Share by Country (2021–2032)

Figure 50. Turkey Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Saudi Arabia Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. UAE Albumin (as Excipient) Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Global Sales Market Share of Albumin (as Excipient) by Type (2021–2032)

Figure 54. Global Revenue Market Share of Albumin (as Excipient) by Type (2021–2032)

Figure 55. Global Albumin (as Excipient) Price (USD/Kg) by Type (2021–2032)

Figure 56. Global Sales Market Share of Albumin (as Excipient) by Application (2021–2032)

Figure 57. Global Revenue Market Share of Albumin (as Excipient) by Application (2021–2032)

Figure 58. Global Albumin (as Excipient) Price (USD/Kg) by Application (2021–2032)

Figure 59. Albumin (as Excipient) Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Pharmaceutical Excipient Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Plasma Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Serum Albumin Market Research Report 2025

Blood Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Albumin Market Research Report 2025

Global Albumin Pharmaceutical Preparations Market Research Report 2024

Global rHu Albumin Market Research Report 2024

Global Blood Banking and Blood Products Market Research Report 2024

Global Human Albumin Solution Market Research Report 2024

Global Albumin Testing Market Research Report 2024

Dry Bovine Serum Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Colloids Blood Plasma Market Research Report 2025

Human Albumin Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Serum Albumin Fusion Protein Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Plasma Protein Products Market Research Report 2024

Blood Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Globular Protein Market Insights Forecast to 2030

Global Glycated Albumin Market Insights Forecast to 2030

Global Human Plasma Protein Products Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions